NEO-CYTAMEN

This brand name is authorized in Ireland, United Kingdom

Active ingredients

The drug NEO-CYTAMEN contains one active pharmaceutical ingredient (API):

1 Vitamin B12a UNII Q40X8H422O - HYDROXOCOBALAMIN

Hydroxocobalamin is a cyanide antidote. Its action in the treatment of cyanide poisoning is based on its ability to bind cyanide ions. Each hydroxocobalamin molecule can bind one cyanide ion by substituting it for the hydroxo ligand linked to the trivalent cobalt ion, to form cyanocobalamin, which is then excreted in the urine. Read about Vitamin B12a

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NEO-CYTAMEN Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03BA03	Hydroxocobalamin	B Blood and blood forming organs → B03 Antianemic preparations → B03B Vitamin B12 and folic acid → B03BA Vitamin B12 (cyanocobalamin and analogues)
Discover more medicines within B03BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 143406, 28595
Country: IE	Health Products Regulatory Authority	Identifier(s): 35882